Tag: PHARMA NEWS
Lupin Introduces Kaveri Therapeutics to Accelerate Cancer Drug Development
Lupin Limited announced the strategic spin-out of two promising oncology assets LNP7457 (PRMT5) and LNP8701 (SOS1) into Kaveri Therapeutics Inc. , a U.S.-based, clinical-stage oncology company dedicated to advancing targeted...
CBN India Seizes Illicit Trafficking of 12 Crore Tramadol Tablets under “Operation Vajra”
The Central Bureau of Narcotics (CBN) successfully executed “Operation Vajra,” seizing a massive export consignment of 120 million (12 crore) high-strength Tramadol Hydrochloride tablets....
DCGI Approves Qdenga, Marking India’s First Dengue Vaccine
Takeda Biopharmaceuticals India has received market authorisation from the Drug Controller General of India (DCGI) for Qdenga, making it the country's first licensed dengue vaccine....
NATCO Gets USFDA Nod for Generic Cancer Drug Olaparib
Alembic Pharmaceuticals Limited announced that its development partner, NATCO Pharma Limited (NATCO), has received tentative approval from the U.S. Food and Drug Administration (USFDA)...
Lupin Earns Great Place To Work® India 2026 Nation Builders Recognition
Lupin Limited (Lupin) announced that it has been recognized among India's Best Employers in the Nation-Builders Category 2026 by Great Place To Work® India, ranking...
Government Reviews Ayushman Bharat, Plans Next Phase of Healthcare Reforms
The National Health Authority concluded its two-day Chintan Shivir on Ayushman Bharat PM-JAY and the Ayushman Bharat Digital Mission, held July 17–18, 2026, in New Delhi. The gathering brought together health...